JP2009529047A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009529047A5 JP2009529047A5 JP2008558335A JP2008558335A JP2009529047A5 JP 2009529047 A5 JP2009529047 A5 JP 2009529047A5 JP 2008558335 A JP2008558335 A JP 2008558335A JP 2008558335 A JP2008558335 A JP 2008558335A JP 2009529047 A5 JP2009529047 A5 JP 2009529047A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrazolo
- phenyl
- yloxy
- fluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 111
- 125000000217 alkyl group Chemical group 0.000 claims 60
- 125000000623 heterocyclic group Chemical group 0.000 claims 54
- -1 cyclopropylidene Chemical group 0.000 claims 53
- 125000003118 aryl group Chemical group 0.000 claims 49
- 125000001072 heteroaryl group Chemical group 0.000 claims 46
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 34
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 28
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 28
- 229910052801 chlorine Inorganic materials 0.000 claims 26
- 150000001875 compounds Chemical class 0.000 claims 25
- 229910052731 fluorine Inorganic materials 0.000 claims 25
- 229910052794 bromium Inorganic materials 0.000 claims 24
- 125000004452 carbocyclyl group Chemical group 0.000 claims 23
- 229910005965 SO 2 Inorganic materials 0.000 claims 21
- 229910052740 iodine Inorganic materials 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims 17
- 125000003342 alkenyl group Chemical group 0.000 claims 15
- 125000000304 alkynyl group Chemical group 0.000 claims 15
- 125000004429 atom Chemical group 0.000 claims 14
- 229910052799 carbon Inorganic materials 0.000 claims 12
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 11
- 229920006395 saturated elastomer Polymers 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000002837 carbocyclic group Chemical group 0.000 claims 3
- 125000002950 monocyclic group Chemical group 0.000 claims 3
- 125000006413 ring segment Chemical group 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- ABWZEYVKVVURNN-UHFFFAOYSA-N C1=CC(=CC=C1N2C(=O)C(=CC=N2)C(=O)N)F.Cl.Cl Chemical compound C1=CC(=CC=C1N2C(=O)C(=CC=N2)C(=O)N)F.Cl.Cl ABWZEYVKVVURNN-UHFFFAOYSA-N 0.000 claims 2
- 125000002619 bicyclic group Chemical group 0.000 claims 2
- FEHLGOYZDFFMND-UHFFFAOYSA-N cyclopropane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CC1 FEHLGOYZDFFMND-UHFFFAOYSA-N 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 1
- 125000006736 (C6-C20) aryl group Chemical group 0.000 claims 1
- QAVYDPMCCPMIMA-UHFFFAOYSA-N 1-(1,3-benzoxazol-2-yl)-n-[4-[[3-[4-(dimethylamino)piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]cyclopropane-1-carboxamide Chemical compound C1CC(N(C)C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C4(CC4)C=4OC5=CC=CC=C5N=4)=CC=3)F)=C12 QAVYDPMCCPMIMA-UHFFFAOYSA-N 0.000 claims 1
- FXUKPCLDNDAEHQ-UHFFFAOYSA-N 1-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-pyridin-2-ylurea Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)NC1=CC=CC=N1 FXUKPCLDNDAEHQ-UHFFFAOYSA-N 0.000 claims 1
- IKSRPHLQEGXXGS-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]cyclopropane-1,1-dicarboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 IKSRPHLQEGXXGS-UHFFFAOYSA-N 0.000 claims 1
- YTMOLVGYLBFYEJ-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[[3-[2-(4-methylpiperazin-1-yl)ethyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1CN(C)CCN1CCC1=NNC2=NC=CC(OC=3C(=CC(=CC=3)N(C(=O)C3(CC3)C(N)=O)C=3C=CC(F)=CC=3)F)=C12 YTMOLVGYLBFYEJ-UHFFFAOYSA-N 0.000 claims 1
- RQDGTOYZOBSJDZ-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[[3-[3-(methylcarbamoyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound CNC(=O)C1=CC=CC(C=2C3=C(OC=4C(=CC(=CC=4)N(C(=O)C4(CC4)C(N)=O)C=4C=CC(F)=CC=4)F)C=CN=C3NN=2)=C1 RQDGTOYZOBSJDZ-UHFFFAOYSA-N 0.000 claims 1
- LHMHIVIVMVOYLE-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[[3-[5-[(4-methylpiperazin-1-yl)methyl]furan-3-yl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1CN(C)CCN1CC1=CC(C=2C3=C(OC=4C(=CC(=CC=4)N(C(=O)C4(CC4)C(N)=O)C=4C=CC(F)=CC=4)F)C=CN=C3NN=2)=CO1 LHMHIVIVMVOYLE-UHFFFAOYSA-N 0.000 claims 1
- DUJXTXVAJACGSD-UHFFFAOYSA-N 2-(1,3-benzoxazol-2-yl)-n-[4-[[3-[4-(dimethylamino)piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]acetamide Chemical compound C1CC(N(C)C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)CC=4OC5=CC=CC=C5N=4)=CC=3)F)=C12 DUJXTXVAJACGSD-UHFFFAOYSA-N 0.000 claims 1
- XIHLQKAIDPWUBD-UHFFFAOYSA-N 2-(4-fluorophenyl)-N-[3-fluoro-4-[[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C5=CNN=C5)=NNC=4N=CC=3)=CC=2)=CC=N1 XIHLQKAIDPWUBD-UHFFFAOYSA-N 0.000 claims 1
- CBFAVFULWUWDGH-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[2-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]pyrimidin-5-yl]-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(N=C1)=NC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 CBFAVFULWUWDGH-UHFFFAOYSA-N 0.000 claims 1
- CAHHJGBCLQZQOM-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[(3-piperazin-1-yl-1h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(N5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 CAHHJGBCLQZQOM-UHFFFAOYSA-N 0.000 claims 1
- SPCVWZIVKSEQKR-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[(3-piperidin-4-yl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 SPCVWZIVKSEQKR-UHFFFAOYSA-N 0.000 claims 1
- CLLRKPIKZGXPNG-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[(3-pyridin-3-yl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C=5C=NC=CC=5)=NNC=4N=CC=3)=CC=2)=CC=N1 CLLRKPIKZGXPNG-UHFFFAOYSA-N 0.000 claims 1
- RWTYLSUDJBYXHX-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(1,2,3,6-tetrahydropyridin-4-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C=5CCNCC=5)=NNC=4N=CC=3)=CC=2)=CC=N1 RWTYLSUDJBYXHX-UHFFFAOYSA-N 0.000 claims 1
- RCERBRZFXRIRIT-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(1-piperidin-4-ylpyrazol-4-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C5=CN(N=C5)C5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 RCERBRZFXRIRIT-UHFFFAOYSA-N 0.000 claims 1
- IDWKWRRAUUARSD-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(4-piperazin-1-ylphenyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C=5C=CC(=CC=5)N5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 IDWKWRRAUUARSD-UHFFFAOYSA-N 0.000 claims 1
- UUMQLVCYOXAKEC-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(4-propan-2-ylpiperazine-1-carbonyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C(C)C)CCN1C(=O)C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 UUMQLVCYOXAKEC-UHFFFAOYSA-N 0.000 claims 1
- SWFJTRDTGFQNNG-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(4-pyrrolidin-1-ylpiperidin-1-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(N5CCC(CC5)N5CCCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 SWFJTRDTGFQNNG-UHFFFAOYSA-N 0.000 claims 1
- ARWJOZPFUSMKES-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(piperidin-4-ylamino)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(NC5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 ARWJOZPFUSMKES-UHFFFAOYSA-N 0.000 claims 1
- LMNNRVRRULMESK-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(piperidin-4-ylmethyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(CC5CCNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 LMNNRVRRULMESK-UHFFFAOYSA-N 0.000 claims 1
- YKYQEFHSHJBTAO-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(pyrrolidin-3-ylamino)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(NC5CNCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 YKYQEFHSHJBTAO-UHFFFAOYSA-N 0.000 claims 1
- DJFGVFOSGODYGW-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-[(1-propan-2-ylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C(C)C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 DJFGVFOSGODYGW-UHFFFAOYSA-N 0.000 claims 1
- QYHCRZYLKDBYKA-HSZRJFAPSA-N 2-(4-fluorophenyl)-n-[3-fluoro-4-[[3-[(2r)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(N5[C@H](CCC5)CN5CCCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 QYHCRZYLKDBYKA-HSZRJFAPSA-N 0.000 claims 1
- SICGKDJUHCIWIA-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[6-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]pyridin-3-yl]-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 SICGKDJUHCIWIA-UHFFFAOYSA-N 0.000 claims 1
- HIGVKGMGGRNDOG-UHFFFAOYSA-N 2-(cyclohexylmethyl)-5-[3-fluoro-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-methylpyrimidin-4-one Chemical compound N=1C=C(C=2C=C(F)C(OC=3C=4C(C=5C=CC(=CC=5)C(=O)N5CCOCC5)=NNC=4N=CC=3)=CC=2)C(=O)N(C)C=1CC1CCCCC1 HIGVKGMGGRNDOG-UHFFFAOYSA-N 0.000 claims 1
- ZEHHLYMHSQRGNJ-UHFFFAOYSA-N 2-(cyclopropylmethylamino)-5-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-methylpyrimidin-4-one Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1C(C(N1C)=O)=CN=C1NCC1CC1 ZEHHLYMHSQRGNJ-UHFFFAOYSA-N 0.000 claims 1
- ZICAZXCZHGFFQS-UHFFFAOYSA-N 2-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]anilino]-n-(4-fluorophenyl)pyridine-3-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC=4C(=CC=CN=4)C(=O)NC=4C=CC(F)=CC=4)=CC=3)F)=C12 ZICAZXCZHGFFQS-UHFFFAOYSA-N 0.000 claims 1
- LDUGMDDJWJCONU-UHFFFAOYSA-N 2-anilino-5-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-3-methylpyrimidin-4-one Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1C(C(N1C)=O)=CN=C1NC1=CC=CC=C1 LDUGMDDJWJCONU-UHFFFAOYSA-N 0.000 claims 1
- BIQZYBBVDZAVPZ-UHFFFAOYSA-N 2-anilino-5-[3-fluoro-4-[[3-(4-fluorophenyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-methylpyrimidin-4-one Chemical compound N=1C=C(C=2C=C(F)C(OC=3C=4C(C=5C=CC(F)=CC=5)=NNC=4N=CC=3)=CC=2)C(=O)N(C)C=1NC1=CC=CC=C1 BIQZYBBVDZAVPZ-UHFFFAOYSA-N 0.000 claims 1
- WFHKRJMKNVHPAS-UHFFFAOYSA-N 2-anilino-5-[3-fluoro-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-methylpyrimidin-4-one Chemical compound N=1C=C(C=2C=C(F)C(OC=3C=4C(C=5C=CC(=CC=5)C(=O)N5CCOCC5)=NNC=4N=CC=3)=CC=2)C(=O)N(C)C=1NC1=CC=CC=C1 WFHKRJMKNVHPAS-UHFFFAOYSA-N 0.000 claims 1
- UBAWQZFXFMKRDQ-UHFFFAOYSA-N 3-(4-fluorophenyl)-n-[3-fluoro-4-[(3-piperazin-1-yl-1h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-oxo-3-azabicyclo[3.1.0]hexane-1-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C2(C(=O)NC=3C=C(F)C(OC=4C=5C(N6CCNCC6)=NNC=5N=CC=4)=CC=3)CC2C1 UBAWQZFXFMKRDQ-UHFFFAOYSA-N 0.000 claims 1
- CWFPETGAOXZZMK-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl]-5-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]pyrimidin-4-one Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1C(C1=O)=CN=CN1CC1=CC=C(Cl)C=C1 CWFPETGAOXZZMK-UHFFFAOYSA-N 0.000 claims 1
- UWJXMGKPTGPXPO-UHFFFAOYSA-N 3-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-1,4-dihydroquinazolin-2-one Chemical compound C1C2=CC=CC=C2NC(=O)N1C(C=C1F)=CC=C1OC1=C2C(C)=NNC2=NC=C1 UWJXMGKPTGPXPO-UHFFFAOYSA-N 0.000 claims 1
- LFXAGJXLAYLHGR-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(4-propan-2-ylpiperazine-1-carbonyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyrazine-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(=O)C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)C=CN=4)=O)=CC=3)F)=C12 LFXAGJXLAYLHGR-UHFFFAOYSA-N 0.000 claims 1
- DQPHFHDECJHGPS-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-[3-fluoro-4-[[3-(piperidin-4-ylmethyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyrazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(CC5CCNCC5)=NNC=4N=CC=3)=CC=2)=NC=C1 DQPHFHDECJHGPS-UHFFFAOYSA-N 0.000 claims 1
- WTWMYVHNSSMCSG-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-[3-fluoro-4-[[3-[(1-propan-2-ylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyrazine-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)C=CN=4)=O)=CC=3)F)=C12 WTWMYVHNSSMCSG-UHFFFAOYSA-N 0.000 claims 1
- LAPVFEUWCXXCQS-UHFFFAOYSA-N 4-[4-[2-fluoro-4-[[1-[(4-fluorophenyl)carbamoyl]cyclopropanecarbonyl]amino]phenoxy]-2h-pyrazolo[3,4-b]pyridin-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C4(CC4)C(=O)NC=4C=CC(F)=CC=4)=CC=3)F)=C12 LAPVFEUWCXXCQS-UHFFFAOYSA-N 0.000 claims 1
- KDJYKPDYWKWGKJ-UHFFFAOYSA-N 4-benzyl-n-[3-fluoro-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxopyrazine-2-carboxamide Chemical compound C=1C=C(OC=2C=3C(C=4C=CC(=CC=4)C(=O)N4CCOCC4)=NNC=3N=CC=2)C(F)=CC=1NC(=O)C(C1=O)=NC=CN1CC1=CC=CC=C1 KDJYKPDYWKWGKJ-UHFFFAOYSA-N 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- YXCUZSXWFOTQIS-UHFFFAOYSA-N [3-[[4-[2-fluoro-4-[[2-(4-fluorophenyl)-3-oxopyridazine-4-carbonyl]amino]phenoxy]-1h-pyrazolo[3,4-b]pyridin-3-yl]amino]cyclohexyl] 2,2,2-trifluoroacetate Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(NC5CC(CCC5)OC(=O)C(F)(F)F)=NNC=4N=CC=3)=CC=2)=CC=N1 YXCUZSXWFOTQIS-UHFFFAOYSA-N 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 150000001717 carbocyclic compounds Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- DCVLOIOMXXTLHE-UHFFFAOYSA-N methyl 4-[2-fluoro-4-[[2-(4-fluorophenyl)-3-oxopyridazine-4-carbonyl]amino]phenoxy]-2h-pyrazolo[3,4-b]pyridine-3-carboxylate Chemical compound C=12C(C(=O)OC)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 DCVLOIOMXXTLHE-UHFFFAOYSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- PPPLBGVCEQCLFW-UHFFFAOYSA-N n-[2,3-difluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1F)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 PPPLBGVCEQCLFW-UHFFFAOYSA-N 0.000 claims 1
- AKXLXFHSBDEXOA-UHFFFAOYSA-N n-[2,5-difluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC(F)=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 AKXLXFHSBDEXOA-UHFFFAOYSA-N 0.000 claims 1
- VIEWECCEKTXACR-UHFFFAOYSA-N n-[2-chloro-5-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC(Cl)=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 VIEWECCEKTXACR-UHFFFAOYSA-N 0.000 claims 1
- XLNPLMDBUKUWRC-UHFFFAOYSA-N n-[2-chloro-5-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=C(Cl)C=3)F)=C12 XLNPLMDBUKUWRC-UHFFFAOYSA-N 0.000 claims 1
- GZIYTHBKELBBCJ-UHFFFAOYSA-N n-[2-chloro-5-methyl-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound ClC=1C=C(OC=2C=3C(C=4C=CC(=CC=4)C(=O)N4CCOCC4)=NNC=3N=CC=2)C(C)=CC=1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 GZIYTHBKELBBCJ-UHFFFAOYSA-N 0.000 claims 1
- SRJUSQCMBAUMJH-UHFFFAOYSA-N n-[3-fluoro-4-(1-methyl-3-phenylpyrazolo[3,4-b]pyridin-4-yl)oxyphenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C12=C(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)C=CN=C2N(C)N=C1C1=CC=CC=C1 SRJUSQCMBAUMJH-UHFFFAOYSA-N 0.000 claims 1
- YUGBUKDMWDFNCT-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1=CC=C(F)C=C1 YUGBUKDMWDFNCT-UHFFFAOYSA-N 0.000 claims 1
- AIMIMKZRQBMDNL-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-1-(4-fluorophenyl)-2-oxopyrrolidine-3-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)CCN1C1=CC=C(F)C=C1 AIMIMKZRQBMDNL-UHFFFAOYSA-N 0.000 claims 1
- AGJFHMIXRRVAML-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-1-methyl-2-oxopyridine-3-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C1=CC=CN(C)C1=O AGJFHMIXRRVAML-UHFFFAOYSA-N 0.000 claims 1
- IQEWMAABOBFSHI-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-1-methyl-2-oxopyrrolidine-3-carboxamide Chemical compound O=C1N(C)CCC1C(=O)NC(C=C1F)=CC=C1OC1=CC=NC2=C1C(C)=NN2 IQEWMAABOBFSHI-UHFFFAOYSA-N 0.000 claims 1
- GOQLLKXDNDUHSB-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 GOQLLKXDNDUHSB-UHFFFAOYSA-N 0.000 claims 1
- GHSFYNJGDFMLJF-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-methyl-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C1=CC=NN(C)C1=O GHSFYNJGDFMLJF-UHFFFAOYSA-N 0.000 claims 1
- FACGQBFORBZHTQ-UHFFFAOYSA-N n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-oxopyrrolidine-3-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C1CCNC1=O FACGQBFORBZHTQ-UHFFFAOYSA-N 0.000 claims 1
- UXTVSZGDDHVMEA-UHFFFAOYSA-N n-[3-fluoro-4-[(3-morpholin-4-yl-1h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(N5CCOCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 UXTVSZGDDHVMEA-UHFFFAOYSA-N 0.000 claims 1
- UPHNONJFFAIKJN-UHFFFAOYSA-N n-[3-fluoro-4-[3-(4-fluorophenyl)-1-methylpyrazolo[3,4-b]pyridin-4-yl]oxyphenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C12=C(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)C=CN=C2N(C)N=C1C1=CC=C(F)C=C1 UPHNONJFFAIKJN-UHFFFAOYSA-N 0.000 claims 1
- RUUBBFCLUPQERU-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-5-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1C2N(C)CCC2CN1C(C=12)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 RUUBBFCLUPQERU-UHFFFAOYSA-N 0.000 claims 1
- SVVDUAKUJFHGJD-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(1-methylimidazol-2-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound CN1C=CN=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 SVVDUAKUJFHGJD-UHFFFAOYSA-N 0.000 claims 1
- LRPRDPICHSVJML-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(1-methylpiperidin-4-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C)CCC1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 LRPRDPICHSVJML-UHFFFAOYSA-N 0.000 claims 1
- IIYYUWQAKQROIQ-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(1-methylpyrazol-4-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=NN(C)C=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 IIYYUWQAKQROIQ-UHFFFAOYSA-N 0.000 claims 1
- RFSQNGPJNPNDCK-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(2-hydroxyethyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(CCO)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 RFSQNGPJNPNDCK-UHFFFAOYSA-N 0.000 claims 1
- QTIVYMJAXPRBIO-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(2-methylphenyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound CC1=CC=CC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 QTIVYMJAXPRBIO-UHFFFAOYSA-N 0.000 claims 1
- GQJDUMOWYYLAJY-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(3-methylimidazol-4-yl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound CN1C=NC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 GQJDUMOWYYLAJY-UHFFFAOYSA-N 0.000 claims 1
- LMZCBIGNHHETEY-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(4-fluorophenyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 LMZCBIGNHHETEY-UHFFFAOYSA-N 0.000 claims 1
- CXDZBCUUEUIHGN-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(4-methylpiperazin-1-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxo-2-pyridin-2-ylpyridazine-4-carboxamide Chemical compound C1CN(C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5N=CC=CC=5)N=CC=4)=O)=CC=3)F)=C12 CXDZBCUUEUIHGN-UHFFFAOYSA-N 0.000 claims 1
- UGJBEVKDQMSDPR-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(4-methylpiperazine-1-carbonyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C)CCN1C(=O)C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 UGJBEVKDQMSDPR-UHFFFAOYSA-N 0.000 claims 1
- RNQJUHKUZGBCNR-UHFFFAOYSA-N n-[3-fluoro-4-[[3-(oxan-4-ylamino)-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(NC5CCOCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 RNQJUHKUZGBCNR-UHFFFAOYSA-N 0.000 claims 1
- MQYOGDYNVXAYQA-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-(4-fluorophenyl)-2-oxoazepane-3-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C4C(N(C=5C=CC(F)=CC=5)CCCC4)=O)=CC=3)F)=C12 MQYOGDYNVXAYQA-UHFFFAOYSA-N 0.000 claims 1
- ZTESXMAKJAHPAE-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)C=CC=4)=O)=CC=3)F)=C12 ZTESXMAKJAHPAE-UHFFFAOYSA-N 0.000 claims 1
- MZABKBDFFVWSPY-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 MZABKBDFFVWSPY-UHFFFAOYSA-N 0.000 claims 1
- UONAEXMYVRONMC-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-oxo-2-pyridin-2-ylpyridazine-4-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5N=CC=CC=5)N=CC=4)=O)=CC=3)F)=C12 UONAEXMYVRONMC-UHFFFAOYSA-N 0.000 claims 1
- AYWOXSRJQVYOIJ-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-3-phenylbenzamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C=C(C=CC=4)C=4C=CC=CC=4)=CC=3)F)=C12 AYWOXSRJQVYOIJ-UHFFFAOYSA-N 0.000 claims 1
- LXJSRWDKZGPIHC-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-4-(4-fluorophenyl)-3-oxopyrazine-2-carboxamide Chemical compound C1CN(C)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)C=CN=4)=O)=CC=3)F)=C12 LXJSRWDKZGPIHC-UHFFFAOYSA-N 0.000 claims 1
- LTGITATXWVOHAZ-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(3-hydroxycyclohexyl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1C(O)CCCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 LTGITATXWVOHAZ-UHFFFAOYSA-N 0.000 claims 1
- JBMUNMIFFUSBKL-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-4-(4-fluorophenyl)-3-oxopyrazine-2-carboxamide Chemical compound CN1C(C2)CCC1CC2NC(C=12)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=NC=CN1C1=CC=C(F)C=C1 JBMUNMIFFUSBKL-UHFFFAOYSA-N 0.000 claims 1
- JOPQLIAQRRMRSE-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[4-(2-methoxyethyl)piperazin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(CCOC)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 JOPQLIAQRRMRSE-UHFFFAOYSA-N 0.000 claims 1
- BTYJBHVLVJLKTN-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[4-(methylamino)piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CC(NC)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 BTYJBHVLVJLKTN-UHFFFAOYSA-N 0.000 claims 1
- IVTRVOWFNZWCSL-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[4-(methylcarbamoyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-1-methyl-2-oxopyrrolidine-3-carboxamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C4C(N(C)CC4)=O)=CC=3)F)=C12 IVTRVOWFNZWCSL-UHFFFAOYSA-N 0.000 claims 1
- VIZFVZDWCKQICZ-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C=5C=CC(=CC=5)C(=O)N5CCOCC5)=NNC=4N=CC=3)=CC=2)=CC=N1 VIZFVZDWCKQICZ-UHFFFAOYSA-N 0.000 claims 1
- QADUINPLQNGMAM-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[4-(morpholine-4-carbonyl)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-4-methyl-3-oxopyrazine-2-carboxamide Chemical compound O=C1N(C)C=CN=C1C(=O)NC(C=C1F)=CC=C1OC1=CC=NC2=C1C(C=1C=CC(=CC=1)C(=O)N1CCOCC1)=NN2 QADUINPLQNGMAM-UHFFFAOYSA-N 0.000 claims 1
- BUAHSOJGMDGSOU-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[[1-(2-fluoroethyl)piperidin-4-yl]amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(CCF)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 BUAHSOJGMDGSOU-UHFFFAOYSA-N 0.000 claims 1
- NFUHTWNHZCURNS-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[[1-(2-hydroxyethyl)piperidin-4-yl]amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CN(CCO)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 NFUHTWNHZCURNS-UHFFFAOYSA-N 0.000 claims 1
- ZXELOZQYQABKCF-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[[1-(2-methoxyethyl)piperidin-4-yl]amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(CCOC)CCC1NC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 ZXELOZQYQABKCF-UHFFFAOYSA-N 0.000 claims 1
- GAHXXXBESXMEQG-UHFFFAOYSA-N n-[3-fluoro-4-[[3-[methyl-(1-methylpiperidin-4-yl)amino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound N=1NC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C2C=1N(C)C1CCN(C)CC1 GAHXXXBESXMEQG-UHFFFAOYSA-N 0.000 claims 1
- SQQPXGFYGGHUCL-UHFFFAOYSA-N n-[4-[[3-(3-chlorophenyl)-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=C(F)C(OC=3C=4C(C=5C=C(Cl)C=CC=5)=NNC=4N=CC=3)=CC=2)=CC=N1 SQQPXGFYGGHUCL-UHFFFAOYSA-N 0.000 claims 1
- ZHJSJSQWLMHTGQ-UHFFFAOYSA-N n-[4-[[3-[(1-ethylpiperidin-4-yl)methyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-4-(4-fluorophenyl)-3-oxopyrazine-2-carboxamide Chemical compound C1CN(CC)CCC1CC1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)C=CN=4)=O)=CC=3)F)=C12 ZHJSJSQWLMHTGQ-UHFFFAOYSA-N 0.000 claims 1
- MYDPMRDRYKLTGU-HXUWFJFHSA-N n-[4-[[3-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1[C@H](N(C)C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 MYDPMRDRYKLTGU-HXUWFJFHSA-N 0.000 claims 1
- RQLHHRJWUPJIFN-UHFFFAOYSA-N n-[4-[[3-[2-[(dimethylamino)methyl]piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound CN(C)CC1CCCCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 RQLHHRJWUPJIFN-UHFFFAOYSA-N 0.000 claims 1
- DFSOIXFJBFCGHY-UHFFFAOYSA-N n-[4-[[3-[3-(dimethylamino)propylamino]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(NCCCN(C)C)=NNC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 DFSOIXFJBFCGHY-UHFFFAOYSA-N 0.000 claims 1
- QOENHNXLNBSTKP-UHFFFAOYSA-N n-[4-[[3-[4-(dimethylamino)phenyl]-2h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 QOENHNXLNBSTKP-UHFFFAOYSA-N 0.000 claims 1
- NEFBUIHSRZKYJD-UHFFFAOYSA-N n-[4-[[3-[4-(dimethylamino)piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C1CC(N(C)C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C=4C(N(C=5C=CC(F)=CC=5)N=CC=4)=O)=CC=3)F)=C12 NEFBUIHSRZKYJD-UHFFFAOYSA-N 0.000 claims 1
- UGTRUZIPOLZFMT-UHFFFAOYSA-N n-[4-[[3-[4-(dimethylamino)piperidin-1-yl]-1h-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-2-oxo-3-azabicyclo[3.1.0]hexane-1-carboxamide Chemical compound C1CC(N(C)C)CCN1C1=NNC2=NC=CC(OC=3C(=CC(NC(=O)C45C(C4)CN(C5=O)C=4C=CC(F)=CC=4)=CC=3)F)=C12 UGTRUZIPOLZFMT-UHFFFAOYSA-N 0.000 claims 1
- VJOLBFHEBPXHII-UHFFFAOYSA-N n-[5-chloro-2-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide Chemical compound C=12C(C)=NNC2=NC=CC=1OC(C(=C1)Cl)=CC(F)=C1NC(=O)C(C1=O)=CC=NN1C1=CC=C(F)C=C1 VJOLBFHEBPXHII-UHFFFAOYSA-N 0.000 claims 1
- XYVCJSMWTFHTQN-UHFFFAOYSA-N n-benzyl-n-[3-fluoro-4-[(3-methyl-2h-pyrazolo[3,4-b]pyridin-4-yl)oxy]phenyl]acetamide Chemical compound C=1C=C(OC=2C=3C(C)=NNC=3N=CC=2)C(F)=CC=1N(C(=O)C)CC1=CC=CC=C1 XYVCJSMWTFHTQN-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 claims 1
- 0 CN(***C1(*)C(C(*)(*)**)=*)C1=C Chemical compound CN(***C1(*)C(C(*)(*)**)=*)C1=C 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77980506P | 2006-03-07 | 2006-03-07 | |
| US87483206P | 2006-12-14 | 2006-12-14 | |
| PCT/US2007/005583 WO2007103308A2 (en) | 2006-03-07 | 2007-03-06 | Heterobicyclic pyrazole compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009529047A JP2009529047A (ja) | 2009-08-13 |
| JP2009529047A5 true JP2009529047A5 (https=) | 2010-04-30 |
Family
ID=38475465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008558335A Pending JP2009529047A (ja) | 2006-03-07 | 2007-03-06 | ヘテロ二環系ピラゾール化合物およびその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7723330B2 (https=) |
| EP (1) | EP2001880A2 (https=) |
| JP (1) | JP2009529047A (https=) |
| KR (1) | KR20080110783A (https=) |
| AR (1) | AR059887A1 (https=) |
| AU (1) | AU2007224020A1 (https=) |
| BR (1) | BRPI0708615A2 (https=) |
| CA (1) | CA2645137A1 (https=) |
| CL (1) | CL2007000601A1 (https=) |
| CO (1) | CO6140061A2 (https=) |
| CR (1) | CR10338A (https=) |
| EC (1) | ECSP088791A (https=) |
| IL (1) | IL193587A0 (https=) |
| MA (1) | MA31339B1 (https=) |
| MX (1) | MX2008011220A (https=) |
| NO (1) | NO20084183L (https=) |
| RU (1) | RU2008139599A (https=) |
| TW (1) | TW200800996A (https=) |
| WO (1) | WO2007103308A2 (https=) |
| ZA (1) | ZA200807632B (https=) |
Families Citing this family (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100406567C (zh) * | 2002-01-22 | 2008-07-30 | 生物材料公司 | 生物可降解聚合物的干燥方法 |
| EP1831225A2 (en) | 2004-11-19 | 2007-09-12 | The Regents of the University of California | Anti-inflammatory pyrazolopyrimidines |
| WO2007103308A2 (en) * | 2006-03-07 | 2007-09-13 | Array Biopharma Inc. | Heterobicyclic pyrazole compounds and methods of use |
| WO2007114926A2 (en) | 2006-04-04 | 2007-10-11 | The Regents Of The University Of California | Kinase antagonists |
| JP2009539878A (ja) * | 2006-06-08 | 2009-11-19 | アレイ バイオファーマ、インコーポレイテッド | キノリン化合物および使用方法 |
| RU2451676C2 (ru) * | 2006-08-16 | 2012-05-27 | Ф.Хоффманн-Ля Рош Аг | Ненуклеозидные ингибиторы обратной транскриптазы |
| US7776857B2 (en) * | 2007-04-05 | 2010-08-17 | Amgen Inc. | Aurora kinase modulators and method of use |
| PL2183254T3 (pl) | 2007-08-29 | 2017-10-31 | Methylgene Inc | Inhibitory aktywności białkowej kinazy tyrozynowej |
| GB2467670B (en) | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| MX2010007419A (es) | 2008-01-04 | 2010-11-12 | Intellikine Inc | Ciertas entidades quimicas, composiciones y metodos. |
| CA2711614A1 (en) | 2008-01-08 | 2009-07-16 | Array Biopharma Inc. | Pyrrolopyridines as kinase inhibitors |
| CA2711741A1 (en) | 2008-01-09 | 2009-07-16 | Array Biopharma Inc. | Pyrazolopyridines as kinase inhibitors |
| JP5693239B2 (ja) * | 2008-01-23 | 2015-04-01 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ４−ピリジノン化合物および癌についてのその使用 |
| WO2009095752A1 (en) * | 2008-01-29 | 2009-08-06 | Glenmark Pharmaceuticals, S.A. | Fused pyrazole derivatives as cannabinoid receptor modulators |
| KR20100135780A (ko) * | 2008-03-06 | 2010-12-27 | 제넨테크, 인크. | Ｃ-ｍｅｔ 및 ｅｇｆｒ 길항제로의 조합 요법 |
| EP2252293B1 (en) | 2008-03-14 | 2018-06-27 | Intellikine, LLC | Kinase inhibitors and methods of use |
| US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
| JP5506788B2 (ja) * | 2008-06-09 | 2014-05-28 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換４−（インダゾリル）−１，４−ジヒドロピリジン類およびそれらの使用方法 |
| WO2009149836A1 (en) * | 2008-06-09 | 2009-12-17 | Bayer Schering Pharma Aktiengesellschaft | Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof |
| BRPI0915231A2 (pt) | 2008-07-08 | 2018-06-12 | Intellikine Inc | compostos inibidores de quinase e métodos de uso |
| US20110224223A1 (en) | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof |
| TWI365185B (en) * | 2008-07-24 | 2012-06-01 | Lilly Co Eli | Amidophenoxyindazoles useful as inhibitors of c-met |
| WO2010033941A1 (en) | 2008-09-22 | 2010-03-25 | Array Biopharma Inc. | Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors |
| CA2738429C (en) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
| ES2599458T3 (es) * | 2008-10-14 | 2017-02-01 | Sunshine Lake Pharma Co., Ltd. | Compuestos y métodos de uso |
| KR100961410B1 (ko) * | 2008-10-14 | 2010-06-09 | (주)네오팜 | 단백질 키나제 억제제로서 헤테로사이클릭 화합물 |
| EP2358720B1 (en) | 2008-10-16 | 2016-03-02 | The Regents of The University of California | Fused ring heteroaryl kinase inhibitors |
| MY169791A (en) | 2008-10-22 | 2019-05-15 | Array Biopharma Inc | Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors |
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| JP5486606B2 (ja) * | 2008-11-13 | 2014-05-07 | エクセリクシス， インク． | キノリン誘導体の調製方法 |
| NZ779754A (en) | 2009-01-16 | 2023-04-28 | Exelixis Inc | Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl] oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer |
| JP5789252B2 (ja) | 2009-05-07 | 2015-10-07 | インテリカイン， エルエルシー | 複素環式化合物およびその使用 |
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
| US8846673B2 (en) | 2009-08-11 | 2014-09-30 | Bristol-Myers Squibb Company | Azaindazoles as kinase inhibitors and use thereof |
| NZ598220A (en) | 2009-08-17 | 2014-02-28 | Intellikine Llc | Heterocyclic compounds and uses thereof |
| WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
| CN102666537A (zh) * | 2009-10-20 | 2012-09-12 | 艾格尔生物制药股份有限公司 | 治疗黄病毒科病毒感染的氮杂吲唑 |
| EP2542240B1 (en) * | 2010-03-01 | 2017-04-05 | Novadrug, LLC | Compositions and methods for treating viral diseases |
| CA2800998A1 (en) | 2010-04-29 | 2011-11-10 | Deciphera Pharmaceuticals, Llc | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| ME03376B (me) | 2010-05-20 | 2020-01-20 | Array Biopharma Inc | Makrociklička jedinjenja kао inhibiтori trk kinaze |
| CA2799579A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
| JP2013545749A (ja) | 2010-11-10 | 2013-12-26 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環化合物及びその使用 |
| ES2637113T3 (es) | 2011-01-10 | 2017-10-10 | Infinity Pharmaceuticals, Inc. | Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas |
| EP2487159A1 (en) | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| RU2568258C2 (ru) | 2011-02-28 | 2015-11-20 | Саншайн Лейк Фарма Ко., Лтд | Замещенные соединения хинолина и способы их использования |
| WO2012127472A1 (en) * | 2011-03-22 | 2012-09-27 | Mapi Pharma Ltd. | Process and intermediates for the preparation of preladenant and related compounds |
| AR088218A1 (es) | 2011-07-19 | 2014-05-21 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos utiles como inhibidores de pi3k |
| HK1198443A1 (en) | 2011-07-19 | 2015-04-24 | 无限药品股份有限公司 | Heterocyclic compounds and uses thereof |
| WO2013022519A1 (en) * | 2011-08-10 | 2013-02-14 | Merck Patent Gmbh | Pyrido-pyrimidine derivatives |
| MX2014002542A (es) | 2011-08-29 | 2014-07-09 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos. |
| CA2846496C (en) | 2011-09-02 | 2020-07-14 | The Regents Of The University Of California | Substituted pyrazolo[3,4-d]pyrimidines and uses thereof |
| SG11201400724SA (en) | 2011-09-19 | 2014-04-28 | Genentech Inc | Combination treatments comprising c-met antagonists and b-raf antagonists |
| RU2501800C2 (ru) * | 2012-02-07 | 2013-12-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | 2-(6-АРИЛ-4-АРОИЛ-3-МЕТИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-5-ИЛ)-2-ОКСО-N-АРИЛАЦЕТАМИДЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ |
| WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| WO2014026330A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2014026327A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
| JP2015532287A (ja) | 2012-09-26 | 2015-11-09 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | Ｉｒｅ１の調節 |
| AU2013337717B2 (en) | 2012-11-01 | 2018-10-25 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using PI3 kinase isoform modulators |
| AU2013343105B2 (en) | 2012-11-08 | 2016-04-14 | Pfizer Inc. | Heteroaromatic compounds as dopamine D1 ligands |
| US9260426B2 (en) * | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
| PT3052485T (pt) | 2013-10-04 | 2021-10-22 | Infinity Pharmaceuticals Inc | Compostos heterocíclicos e suas utilizações |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| AU2014370186A1 (en) * | 2013-12-26 | 2016-07-14 | Ignyta, Inc. | Pyrazolo[1,5-a]pyridine derivatives and methods of their use |
| MX382033B (es) | 2014-03-19 | 2025-03-13 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma. |
| RU2016141385A (ru) | 2014-03-24 | 2018-04-28 | Дженентек, Инк. | Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf |
| WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| TW201613919A (en) * | 2014-07-02 | 2016-04-16 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CN113354649B (zh) | 2014-11-16 | 2024-12-10 | 阵列生物制药公司 | 一种新的晶型 |
| CA2975997A1 (en) | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as rorgammat inhibitors and uses thereof |
| EA034571B1 (ru) | 2015-07-31 | 2020-02-21 | Дзе Джонс Хопкинс Юниверсити | Пролекарства аналогов глутамина |
| WO2017048702A1 (en) | 2015-09-14 | 2017-03-23 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| AU2016333855A1 (en) * | 2015-10-09 | 2018-04-26 | AbbVie S.à.r.l. | Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and their use |
| EP3368039A1 (en) | 2015-10-26 | 2018-09-05 | The Regents of The University of Colorado, A Body Corporate | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
| EP3368535B1 (en) | 2015-10-27 | 2020-12-02 | Merck Sharp & Dohme Corp. | Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof |
| JP2018535958A (ja) | 2015-10-27 | 2018-12-06 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | ＲＯＲγＴ阻害薬としての置換インダゾール化合物及びその使用 |
| US10344000B2 (en) | 2015-10-27 | 2019-07-09 | Merck Sharp & Dohme Corp. | Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| FI3439662T3 (fi) | 2016-04-04 | 2024-09-04 | Loxo Oncology Inc | (s)-n-(5-((r)-2-(2,5-difluorifenyyli)pyrrolidin-1-yyli)pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidin nesteformulaatioita |
| US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| EP3458456B1 (en) * | 2016-05-18 | 2020-11-25 | Loxo Oncology Inc. | Preparation of (s)-n-(5-((r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
| MX388576B (es) | 2016-06-07 | 2025-03-20 | Jacobio Pharmaceuticals Co Ltd | Derivados heterociclicos novedosos utiles como inhibidores de shp2. |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| SG11201811237WA (en) | 2016-06-24 | 2019-01-30 | Infinity Pharmaceuticals Inc | Combination therapies |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| EA202190196A1 (ru) | 2017-03-23 | 2021-08-31 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| CN108948002A (zh) * | 2017-05-19 | 2018-12-07 | 厦门大学 | 五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用 |
| EP3638669A1 (en) | 2017-06-13 | 2020-04-22 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyridine-derivatives |
| WO2018228925A1 (en) | 2017-06-13 | 2018-12-20 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyridine-derivatives |
| EP3638670B1 (en) | 2017-06-13 | 2021-07-21 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyridine-derivatives as map4k1 modulators for the treatment of cancer diseases |
| CA3070013A1 (en) | 2017-07-18 | 2019-01-24 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyridine-derivatives |
| WO2019121143A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Substituted cyclopropyl derivatives |
| JP7253498B2 (ja) | 2017-12-22 | 2023-04-06 | 住友化学株式会社 | 複素環化合物及びそれを含有する有害節足動物防除剤 |
| CR20250117A (es) | 2018-01-26 | 2025-05-09 | Exelixis Inc | COMPUESTOS PARA EL TRATAMIENTO DE TRASTORNOS DEPENDIENTES DE CINASAS (Divisional 2020-0355) |
| CA3088198A1 (en) | 2018-01-26 | 2019-08-01 | Exelixis, Inc. | Compounds for the treatment of kinase-dependent disorders |
| AR117398A1 (es) | 2018-03-12 | 2021-08-04 | Abbvie Inc | Inhibidores de la señalización mediada por tirosina cinasa 2 |
| CA3102279A1 (en) | 2018-06-01 | 2019-12-05 | Cornell University | Combination therapy for pi3k-associated disease or disorder |
| UY38349A (es) * | 2018-08-30 | 2020-03-31 | Array Biopharma Inc | Compuestos de pirazolo[3,4-b]piridina como inhibidores de cinasas tam y met |
| US20210393623A1 (en) | 2018-09-26 | 2021-12-23 | Jacobio Pharmaceuticals Co., Ltd. | Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors |
| CN114340734A (zh) * | 2019-06-24 | 2022-04-12 | 博善人工智能生物科技有限公司 | 新化合物和方法 |
| US20220289679A1 (en) * | 2019-07-29 | 2022-09-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP2023504623A (ja) * | 2019-12-04 | 2023-02-06 | アーカス バイオサイエンシーズ，インコーポレーテッド | Ｈｉｆ－２アルファの阻害剤 |
| WO2021163192A1 (en) * | 2020-02-10 | 2021-08-19 | Stemsynergy Therapeutics, Inc. | Myc inhibitors and uses thereof |
| JP2025502358A (ja) * | 2022-01-12 | 2025-01-24 | シェンゼン イオノヴァ ライフ サイエンス カンパニー リミテッド | Ｈｐｋ１阻害剤としてのヘテロアリール化合物およびその使用方法 |
| TW202413341A (zh) | 2022-09-23 | 2024-04-01 | 美商富曼西公司 | 吡唑醯胺殺昆蟲劑 |
| CN117483112B (zh) * | 2023-11-10 | 2026-02-03 | 文山麻栗坡紫金钨业集团有限公司 | 一种新型白钨矿捕收剂及其加温精选选矿工艺 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| ZW12187A1 (en) | 1986-07-03 | 1989-02-01 | Janssen Pharmaceutica Nv | 4-(aroylamino)piperidinebutanamide derivatives |
| AU3262593A (en) | 1992-01-11 | 1993-08-03 | Schering Agrochemicals Limited | Biheterocyclic fungicidal compounds |
| US5252581A (en) | 1992-07-20 | 1993-10-12 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted aminothienopyridines, pharmaceutical composition and use |
| DK0765327T3 (da) | 1994-06-16 | 1999-11-29 | Pfizer | Pyrazolo- og pyrrolopyridiner |
| US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| DE69734521T9 (de) | 1996-08-23 | 2006-12-07 | Sugen, Inc., South San Francisco | Kombinatorische indolinonbibliotheken und verwandte produkte und verfahren zur behandlung von erkrankungen |
| US6251911B1 (en) * | 1996-10-02 | 2001-06-26 | Novartis Ag | Pyrimidine derivatives and processes for the preparation thereof |
| AU747705C (en) | 1997-12-13 | 2004-09-23 | Bristol-Myers Squibb Company | Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors |
| US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
| GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
| US6297238B1 (en) | 1999-04-06 | 2001-10-02 | Basf Aktiengesellschaft | Therapeutic agents |
| US6921763B2 (en) | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
| JP2003509428A (ja) * | 1999-09-17 | 2003-03-11 | アボツト・ゲー・エム・ベー・ハー・ウント・コンパニー・カーゲー | 治療薬としてのピラゾロピリミジン |
| JP2004507455A (ja) | 2000-04-25 | 2004-03-11 | ブリストル−マイヤーズ スクイブ カンパニー | サイクリン依存性キナーゼ阻害剤としての、５−チオ−、スルフィニル−およびスルホニルピラゾロ［３，４−ｂ］−ピリジンの用途 |
| WO2001098301A1 (en) | 2000-06-20 | 2001-12-27 | Japan Tobacco Inc. | Pyrazolopyridine compounds and use thereof as drugs |
| JP2002020386A (ja) * | 2000-07-07 | 2002-01-23 | Ono Pharmaceut Co Ltd | ピラゾロピリジン誘導体 |
| US6599902B2 (en) | 2001-05-30 | 2003-07-29 | Sugen, Inc. | 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| AU2002313249B2 (en) | 2001-06-22 | 2008-08-21 | Kirin Pharma Kabushiki Kaisha | Quinoline derivative and quinazoline derivate inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| DE60218493D1 (de) | 2001-09-12 | 2007-04-12 | Pharmacia & Upjohn Co Llc | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten |
| AU2002357193A1 (en) | 2001-12-19 | 2003-07-09 | Smithkline Beecham Corporation | Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| EP1470131A2 (en) | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| US7312212B2 (en) | 2002-01-29 | 2007-12-25 | Glaxo Group Limited | Aminopiperidine derivatives |
| US6790852B2 (en) | 2002-04-18 | 2004-09-14 | Hoffmann-La Roche Inc. | 2-(2,6-dichlorophenyl)-diarylimidazoles |
| TW200400034A (en) | 2002-05-20 | 2004-01-01 | Bristol Myers Squibb Co | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| GB0211649D0 (en) | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| JP4754821B2 (ja) | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物 |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| EP1558252B1 (en) | 2002-08-02 | 2007-10-10 | Merck & Co., Inc. | Substituted furo [2,3-b]pyridine derivatives |
| EP1545515A1 (en) * | 2002-08-12 | 2005-06-29 | Sugen, Inc. | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| JP2006503108A (ja) | 2002-09-16 | 2006-01-26 | グラクソ グループ リミテッド | ピラゾロ［３，４−ｂ］ピリジン化合物およびそれのホスホジエステラーゼ阻害薬としての使用 |
| GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
| AU2003272740A1 (en) | 2002-10-01 | 2004-04-23 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors |
| AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
| DK1603570T5 (da) | 2003-02-26 | 2013-12-09 | Sugen Inc | Aminoheteroarylforbindelser som proteinkinaseinhibitorer |
| AU2004230841A1 (en) | 2003-04-03 | 2004-10-28 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
| MXPA06000276A (es) | 2003-07-02 | 2006-04-07 | Sugen Inc | Indolinona hidrazidas como inhibidores de c-met. |
| US7122548B2 (en) | 2003-07-02 | 2006-10-17 | Sugen, Inc. | Triazolotriazine compounds and uses thereof |
| US7037909B2 (en) | 2003-07-02 | 2006-05-02 | Sugen, Inc. | Tetracyclic compounds as c-Met inhibitors |
| PE20050730A1 (es) | 2003-08-15 | 2005-09-20 | Merck & Co Inc | Derivados de 2,5-dihidropirrol 2,2-disustituidos como inhibidores de quinesinas mitoticas |
| EP2210607B1 (en) | 2003-09-26 | 2011-08-17 | Exelixis Inc. | N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| AU2004299277A1 (en) | 2003-12-19 | 2005-06-30 | Glaxo Group Limited | Pyrazolo (3,4-b) pyridine compounds, and their use as phosphodiesterase inhibitors |
| JP4805166B2 (ja) | 2003-12-22 | 2011-11-02 | バジリア ファルマスーチカ アーゲー | アロイルフランおよびアロイルチオフェン |
| GEP20084439B (en) | 2004-01-23 | 2008-07-25 | Amgen Inc | Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof |
| WO2005085249A1 (en) * | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Fused derivatives of pyrazole |
| US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
| WO2005121125A1 (en) | 2004-06-09 | 2005-12-22 | Pfizer Inc. | Ether-linked heteroaryl compounds |
| US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
| US7977345B2 (en) | 2004-07-02 | 2011-07-12 | Exelixis, Inc. | c-MET modulators and method of use |
| JP2008521900A (ja) | 2004-11-30 | 2008-06-26 | アムジエン・インコーポレーテツド | キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用 |
| EP1874318A2 (en) | 2005-04-19 | 2008-01-09 | Merck & Co., Inc. | N-alkyl-azacycloalkyl nmda/nr2b antagonists |
| US7470693B2 (en) | 2005-04-21 | 2008-12-30 | Bristol-Myers Squibb Company | Oxalamide derivatives as kinase inhibitors |
| JO2787B1 (en) | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| KR101378716B1 (ko) | 2005-05-20 | 2014-04-10 | 메틸진 인코포레이티드 | Ｖｅｇｆ 수용체 및 ｈｇｆ 수용체 신호전달의 억제제 |
| FR2889526B1 (fr) | 2005-08-04 | 2012-02-17 | Aventis Pharma Sa | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
| WO2007033196A1 (en) | 2005-09-14 | 2007-03-22 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| US7880004B2 (en) | 2005-09-15 | 2011-02-01 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| WO2007103308A2 (en) * | 2006-03-07 | 2007-09-13 | Array Biopharma Inc. | Heterobicyclic pyrazole compounds and methods of use |
| AR060061A1 (es) | 2006-03-22 | 2008-05-21 | Methylgene Inc | Inhibidores de la actividad de la proteina tirosina quinasa |
| NZ579645A (en) * | 2007-03-14 | 2012-01-12 | Ranbaxy Lab Ltd | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| WO2009080534A1 (en) * | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
-
2007
- 2007-03-06 WO PCT/US2007/005583 patent/WO2007103308A2/en not_active Ceased
- 2007-03-06 JP JP2008558335A patent/JP2009529047A/ja active Pending
- 2007-03-06 AU AU2007224020A patent/AU2007224020A1/en not_active Abandoned
- 2007-03-06 CA CA002645137A patent/CA2645137A1/en not_active Abandoned
- 2007-03-06 KR KR1020087024415A patent/KR20080110783A/ko not_active Withdrawn
- 2007-03-06 MX MX2008011220A patent/MX2008011220A/es not_active Application Discontinuation
- 2007-03-06 RU RU2008139599/04A patent/RU2008139599A/ru not_active Application Discontinuation
- 2007-03-06 EP EP07752297A patent/EP2001880A2/en not_active Withdrawn
- 2007-03-06 US US11/714,342 patent/US7723330B2/en not_active Expired - Fee Related
- 2007-03-06 BR BRPI0708615-6A patent/BRPI0708615A2/pt not_active Application Discontinuation
- 2007-03-07 CL CL2007000601A patent/CL2007000601A1/es unknown
- 2007-03-07 AR ARP070100948A patent/AR059887A1/es unknown
- 2007-03-07 TW TW096107890A patent/TW200800996A/zh unknown
-
2008
- 2008-08-21 IL IL193587A patent/IL193587A0/en unknown
- 2008-09-04 ZA ZA2008/07632A patent/ZA200807632B/en unknown
- 2008-09-19 MA MA31254A patent/MA31339B1/fr unknown
- 2008-09-30 CO CO08104090A patent/CO6140061A2/es unknown
- 2008-10-02 CR CR10338A patent/CR10338A/es unknown
- 2008-10-06 EC EC2008008791A patent/ECSP088791A/es unknown
- 2008-10-06 NO NO20084183A patent/NO20084183L/no not_active Application Discontinuation
-
2010
- 2010-01-26 US US12/693,975 patent/US20100256356A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009529047A5 (https=) | ||
| JP7654071B2 (ja) | 複素環スピロ化合物及び使用方法 | |
| JP5911638B2 (ja) | ベンゾチアゾール−６−イル酢酸誘導体およびｈｉｖ感染を処置するためのそれらの使用 | |
| JP6117238B2 (ja) | ブロモドメイン阻害薬 | |
| CA2845578C (en) | Pyrimidine pde10 inhibitors | |
| JP6517790B2 (ja) | ４−アザインドール誘導体 | |
| JP5833010B2 (ja) | 抗癌剤としてのピラゾロピリジン誘導体 | |
| DK2925757T3 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP6509838B2 (ja) | Ｂｔｋ阻害薬としての一級カルボキサミド類 | |
| RU2650895C2 (ru) | Соединения замещенных пиразолонов и способы использования | |
| JP2025535046A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| JP6695353B2 (ja) | Ｆｇｆｒ４阻害剤としてのホルミル化ｎ−複素環式誘導体 | |
| JP2009510161A5 (https=) | ||
| JP2016525135A (ja) | ＢＥＴタンパク質およびポロ様キナーゼの二重阻害薬としての置換されたジヒドロピリド［３，４−ｂ］ピラジノン類 | |
| JP2017531039A5 (https=) | ||
| JP2020510092A5 (https=) | ||
| TW202116753A (zh) | 以噌啉作為hpk1的抑制劑 | |
| KR20140107421A (ko) | Pi3k의 활성 또는 기능의 억제제의 용도 | |
| RU2012130929A (ru) | Гетероциклические соединения в качестве ингибиторов янус-киназы | |
| WO2012044562A2 (en) | Pyrazolopyrimidine pde10 inhibitors | |
| HRP20110332T1 (hr) | TRIAZOLO[1,5-a]KINOLINI KAO LIGANDI ADENOZINSKOG RECEPTORA A3 | |
| US20180170874A1 (en) | Heterocyclic compound | |
| TW202444351A (zh) | 聯芳基衍生物及相關用途 | |
| NZ621245B2 (en) | Pyrimidine pde10 inhibitors |